Fidelity Investments
CRMD icon

Fidelity Investments’s CorMedix CRMD Stock Holding History

Fidelity Investments’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.6K Buy
6,574
+835
+15% +$6.6K ﹤0.01% 4296
2026
Q1 		$39K Sell
5,739
-118,038
-95% -$873K ﹤0.01% 4238
2025
Q4 		$1.44M Buy
123,777
+115,393
+1,376% +$1.28M ﹤0.01% 2715
2025
Q3 		$97.5K Buy
8,384
+608
+8% +$7.35K ﹤0.01% 3674
2025
Q2 		$95.8K Buy
7,776
+958
+14% +$10.6K ﹤0.01% 3623
2025
Q1 		$42K Sell
6,818
-15,135
-69% -$157K ﹤0.01% 3927
2024
Q4 		$178K Buy
21,953
+17,335
+375% +$173K ﹤0.01% 3315
2024
Q3 		$37.3K Buy
4,618
+1,625
+54% +$8.79K ﹤0.01% 3906
2024
Q2 		$13K Buy
2,993
+383
+15% +$1.95K ﹤0.01% 4238
2024
Q1 		$11.1K Sell
2,610
-564
-18% -$1.96K ﹤0.01% 4236
2023
Q4 		$11.9K Buy
3,174
+2,663
+521% +$9.16K ﹤0.01% 4181
2023
Q3 		$1.89K Buy
511
+428
+516% +$1.7K ﹤0.01% 4549
2023
Q2 		$329 Buy
83
+74
+822% +$366 ﹤0.01% 4858
2023
Q1 		$37 Hold
9
– – ﹤0.01% 5013
2022
Q4 		$38 Sell
9
-183
-95% -$647 ﹤0.01% 4995
2022
Q3 		$1K Sell
192
-11
-5% -$46 ﹤0.01% 4642
2022
Q2 		$1K Sell
203
-1,765
-90% -$6.56K ﹤0.01% 4685
2022
Q1 		$11K Buy
+1,968
New +$9.01K ﹤0.01% 4217
2020
Q3 		– Sell
-1,729
Closed -$11K – 3716
2020
Q2 		$11K Buy
+1,729
New +$8K ﹤0.01% 3092

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Fidelity Investments's CRMD Position: Q2 2026 in Review

Fidelity Investments increased its CorMedix (CRMD) stake by 15% in Q2 2026, buying an estimated $6.6K and bringing the position to 6,574 shares worth $51.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4296.

Fidelity Investments first reported a position in CRMD in Q2 2020 and has held it in 19 quarters since. The position peaked at $1.44M in Q4 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Fidelity Investments held 6,574 shares of CorMedix worth $51.6K as of Q2 2026.
  • Fidelity Investments bought 835 CorMedix shares in Q2 2026, an estimated $6.6K.
  • CorMedix made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4296 holding.
  • Fidelity Investments first reported a position in CorMedix in Q2 2020 and has held it in 19 quarters since.
  • Fidelity Investments's CorMedix position peaked at $1.44M in Q4 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.